NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding...

European Journal of Cancer 2016 / 12 Vol. 69

NMS-P088, a CSF-1R, FLT3 and KIT inhibitor with outstanding activity on gatekeeper resistance mutations, high tolerability, and potential for combination therapies

Ardini, E., Lombardi Borgia, A., Texido, G., Alzani, R., Avanzi, N., Amboldi, N., Cribioli, S., Mancini, L., Casero, D., Pastori, W., Montemartini, M., Montagnoli, A., Donati, D., Galvani, A., Isacchi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32980-x
Date:
December, 2016
File:
PDF, 60 KB
english, 2016
Conversion to is in progress
Conversion to is failed